跳到正文

How AI Is Helping Scientists Find Leads in Neurodegenerative Disease Research

OpenAI · X转述· @OpenAI·· 6 小时前精选

5万 次浏览 · 462 赞 · 33 转发 (收录时)

原文

中文版本尚未就绪 · 显示原文

发生了什么

OpenAI points to a drug discovery lead surfaced by GPT-Rosalind: restoring cholesterol transport may help protect neurons from degeneration. In mouse-brain data, disrupting DCTN1, a gene linked to Perry syndrome, increased expression of cholesterol-making genes; GPT-Rosalind suggested cholesterol may not be reaching where neurons need it. A team of thousands of agents connected results from millions of mouse brain cells with scientific literature in 32 minutes, and the collaboration is expanding to identify drug targets.

推荐理由

GPT-Rosalind connected gene-expression results from millions of mouse brain cells with scientific literature in 32 minutes, giving researchers a specific cholesterol-transport mechanism to test for Perry syndrome.

正文 · 中文版本尚未就绪(原文)

How AI is helping scientists uncover new leads for understanding and treating neurodegenerative diseases—and the brain research behind our collaboration with @perturbai_tx and @scrippsresearch:

引用OpenAI@OpenAI

GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?

DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it.

That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders.

With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets.

openai.com/index/scaling-ai-r…

在 X 查看被引用的帖子

这件事到目前为止

OpenAI said GPT-Rosalind proposed impaired cholesterol transport as a possible explanation for increased expression of cholesterol synthesis genes after DCTN1 disruption in mouse-brain data, yielding a mechanism scientists can test. DCTN1 is linked to Perry syndrome, a rare neurodegenerative disorder. Working with PerturbAI and Scripps Research, thousands of GPT-Rosalind agents connected gene-expression results from millions of mouse brain cells with scientific literature in 32 minutes, according to OpenAI. OpenAI presented the proposed mechanism as a drug-discovery lead, asking whether restoring cholesterol transport could protect neurons from degeneration.

接下来读什么

查看这件事的完整进展OpenAI Says GPT-Rosalind Proposed Cholesterol Transport Mechanism for Neurodegeneration Research
这条收录于 11月21日 AI 日报看这一期日报的全部内容